|Bid||269.37 x 800|
|Ask||269.75 x 1300|
|Day's range||266.90 - 271.68|
|52-week range||165.23 - 295.55|
|Beta (5Y monthly)||1.47|
|PE ratio (TTM)||32.61|
|Earnings date||29 Jul 2020 - 03 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||283.91|
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $272.82, moving -1.51% from the previous trading session.
Zacks Market Edge Highlights: Vertex Pharmaceuticals, Channel Advisor, Gold Fields, AngloGold Ashanti and Dropbox
How can the stock market be near another all-time high with a pandemic and 40 million unemployed? Secular bull markets don't care about headlines.
Vertex today announced that Diana McKenzie has been appointed to its board of directors as an independent director.
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
Let's dive into three large-cap pharmaceutical and biotech stocks that appear set to grow during the pandemic-induced downturn and the eventual recovery...
While the broader market indexes are still down year to date despite strong rebounds in recent weeks, the major biotech exchange-traded funds (ETFs) are in solid positive territory for the year. Granted, not all biotech stocks are doing well. If you've got $3,000 to invest, here are three great biotech stocks to buy right now that have what it takes for long-term success.
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
VRTX vs. ILMN: Which Stock Is the Better Value Option?
The answer is yes. There's no need to build any suspense. Vertex Pharmaceuticals (NASDAQ: VRTX) is definitely a great stock to buy right now, in my view. I've owned the biotech stock for a couple of years.
Often the real stock market winners are not shares that look obviously cheap compared to book value or earnings – instead they are the slightly more expensive,...
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
The art of biotech investing requires a great deal of scientific knowledge, awareness of financials, and patience in waiting for clinical trials to come to fruition. Today, let's examine two of the best biotech stocks in the industry; both are companies making rapid progress in treating patients with significant medical needs. Compugen (NASDAQ: CGEN) specializes in clinical-stage cancer immunotherapies, which have proprietary algorithms used to detect specific sequences within protein receptors that regulate the immune system and inhibit autoimmune activity.
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
Uncle Sam could be sending more money your way in the not-too-distant future. Buying these stocks will put the extra cash to good use.